Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors


Target protein identified for improving heart attack treatment

Written by | 22 Jun 2021

A new study led by researchers at Washington State University has identified a protein that could be the key to improving treatment outcomes after a heart attack. Published… read more.

An illuminating possibility for stroke treatment: Nano-photosynthesis

Written by | 11 Jun 2021

Blocked blood vessels in the brains of stroke patients prevent oxygen-rich blood from getting to cells, causing severe damage. Plants and some microbes produce oxygen through photosynthesis. What… read more.

Rejuvenating’ the Alzheimer’s brain

Written by | 8 Jun 2021

Alzheimer’s disease is the main cause of dementia and current therapeutic strategies cannot prevent, slow down or cure the pathology. The disease is characterized by memory loss, caused… read more.

Major step forward in treatment of multiple myeloma

Written by | 19 Apr 2021

Article by Bruce Sylvester A CAR (chimeric antigen receptor) T-cell therapy (idecabtagene vicleucel) more than triples the expected length of remission for multiple myeloma patients who have relapsed… read more.

One in four children want better pain treatment

Written by | 17 Apr 2021

After an appendectomy, a quarter (24.8%) of all children wanted a stronger pain treatment in the first 24 hours after their operation. Among children who had a tonsillectomy,… read more.

Ivermectin mass treatment in perspective

Written by | 17 Feb 2021

Interview and article by Christine Clark. Ivermectin is a good treatment to use interim to and complementary to immunisations, according to Dr David Scheim, one of the authors… read more.

Ivermectin dosing and distribution for mass treatment

Written by | 16 Feb 2021

Interview and article by Christine Clark. Dr David Scheim, one of the authors of a recent study in Peru, describes the doses of ivermectin that were used and… read more.

Results of using ivermectin for mass treatment

Written by | 15 Feb 2021

Interview and article by Christine Clark. Mature, real world data on systematic mass treatment of covid-19 with ivermectin show a sharp fall in excess deaths. IMI interviewed Dr… read more.

Lack of understanding leads to missed heart treatment opportunities

Written by | 10 Dec 2020

Poor awareness of a condition known as Heart Failure with preserved Ejection Fraction (HFpEF) – the cause of a half of all cases of heart failure in England… read more.

Combination treatment appears optimal for high-risk elevated LDL patients

Written by | 8 Sep 2020

Article written by Bruce Sylvester Researchers from a large European study, which included the UK, report that while patients are often able to reduce risks of cardiovascular events… read more.

Is indomethacin a better choice than ibuprofen in covid-19?

Written by | 17 Jun 2020

Interview and article by Christine Clark. Compared with ibuprofen, indomethacin has additional beneficial actions, argues Dr Rajan Ravichandran Commenting on the LIBERATE* study (NCT04334629) that is now in… read more.

Indomethacin to combat cytokine release syndrome in covid-19

Written by | 17 Jun 2020

Interview and article by Christine Clark. Dr Rajan Ravichandran’s experience of using indomethacin to control cytokine release syndrome led him to realise that it could also be useful… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.


You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.